Management of the waiting list for cadaveric kidney transplants: Report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation

Gabriel M. Danovitch, Sundaram Hariharan, John D. Pirsch, David Rush, David Roth, Emilio Ramos, Randall C. Starling, Chuck Cangro, Mattthew R. Weir

Research output: Contribution to journalArticle

85 Citations (Scopus)

Abstract

The Clinical Practice Guidelines Committee of the American Society of Transplantation developed a survey to review the policies of kidney transplant programs in the United States with respect to the management of the steadily expanding waiting list for cadaveric kidneys. The survey was sent to 287 centers, and 192 (67%) responded. The survey indicated that regular follow-up monitoring, most frequently on an annual basis, is required by the majority (71%) of programs. Patients considered to be at high risk and candidates for combined kidney-pancreas transplantation may be monitored more frequently. Annual screening for coronary artery disease is typically required for asymptomatic patients considered to be at high risk for covert disease. Noninvasive techniques are typically used, and a designated cardiologist is usually available to the transplant program. The dialysis nephrologist or the potential transplant recipient is expected to inform the transplant program of intercurrent events that may affect transplant candidacy. Standard health maintenance screening is required, together with the routine updating of serologic and other blood tests that may be relevant to the posttransplant course. Smaller transplant programs (<100 patients on the waiting list) are more likely to maintain closer contact with the wait-listed patients and to attempt to influence their treatment during dialysis and are less likely to cancel transplants because of unanticipated pretransplant medical problems. The work load necessitated by the follow-up monitoring of wait-listed patients was assessed and, in the absence of specific evidence-based information, a series of recommendations were developed to reflect current standards of practice and to suggest future research initiatives.

Original languageEnglish
Pages (from-to)528-535
Number of pages8
JournalJournal of the American Society of Nephrology
Volume13
Issue number2
StatePublished - Feb 9 2002
Externally publishedYes

Fingerprint

Waiting Lists
Practice Guidelines
Transplants
Kidney
Dialysis
Pancreas Transplantation
Hematologic Tests
Workload
Kidney Transplantation
Surveys and Questionnaires
Coronary Artery Disease
Health

ASJC Scopus subject areas

  • Nephrology

Cite this

Management of the waiting list for cadaveric kidney transplants : Report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. / Danovitch, Gabriel M.; Hariharan, Sundaram; Pirsch, John D.; Rush, David; Roth, David; Ramos, Emilio; Starling, Randall C.; Cangro, Chuck; Weir, Mattthew R.

In: Journal of the American Society of Nephrology, Vol. 13, No. 2, 09.02.2002, p. 528-535.

Research output: Contribution to journalArticle

Danovitch, Gabriel M. ; Hariharan, Sundaram ; Pirsch, John D. ; Rush, David ; Roth, David ; Ramos, Emilio ; Starling, Randall C. ; Cangro, Chuck ; Weir, Mattthew R. / Management of the waiting list for cadaveric kidney transplants : Report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation. In: Journal of the American Society of Nephrology. 2002 ; Vol. 13, No. 2. pp. 528-535.
@article{4072873a6eca4703b51ba6787bb6d1f4,
title = "Management of the waiting list for cadaveric kidney transplants: Report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation",
abstract = "The Clinical Practice Guidelines Committee of the American Society of Transplantation developed a survey to review the policies of kidney transplant programs in the United States with respect to the management of the steadily expanding waiting list for cadaveric kidneys. The survey was sent to 287 centers, and 192 (67{\%}) responded. The survey indicated that regular follow-up monitoring, most frequently on an annual basis, is required by the majority (71{\%}) of programs. Patients considered to be at high risk and candidates for combined kidney-pancreas transplantation may be monitored more frequently. Annual screening for coronary artery disease is typically required for asymptomatic patients considered to be at high risk for covert disease. Noninvasive techniques are typically used, and a designated cardiologist is usually available to the transplant program. The dialysis nephrologist or the potential transplant recipient is expected to inform the transplant program of intercurrent events that may affect transplant candidacy. Standard health maintenance screening is required, together with the routine updating of serologic and other blood tests that may be relevant to the posttransplant course. Smaller transplant programs (<100 patients on the waiting list) are more likely to maintain closer contact with the wait-listed patients and to attempt to influence their treatment during dialysis and are less likely to cancel transplants because of unanticipated pretransplant medical problems. The work load necessitated by the follow-up monitoring of wait-listed patients was assessed and, in the absence of specific evidence-based information, a series of recommendations were developed to reflect current standards of practice and to suggest future research initiatives.",
author = "Danovitch, {Gabriel M.} and Sundaram Hariharan and Pirsch, {John D.} and David Rush and David Roth and Emilio Ramos and Starling, {Randall C.} and Chuck Cangro and Weir, {Mattthew R.}",
year = "2002",
month = "2",
day = "9",
language = "English",
volume = "13",
pages = "528--535",
journal = "Journal of the American Society of Nephrology",
issn = "1046-6673",
publisher = "American Society of Nephrology",
number = "2",

}

TY - JOUR

T1 - Management of the waiting list for cadaveric kidney transplants

T2 - Report of a survey and recommendations by the Clinical Practice Guidelines Committee of the American Society of Transplantation

AU - Danovitch, Gabriel M.

AU - Hariharan, Sundaram

AU - Pirsch, John D.

AU - Rush, David

AU - Roth, David

AU - Ramos, Emilio

AU - Starling, Randall C.

AU - Cangro, Chuck

AU - Weir, Mattthew R.

PY - 2002/2/9

Y1 - 2002/2/9

N2 - The Clinical Practice Guidelines Committee of the American Society of Transplantation developed a survey to review the policies of kidney transplant programs in the United States with respect to the management of the steadily expanding waiting list for cadaveric kidneys. The survey was sent to 287 centers, and 192 (67%) responded. The survey indicated that regular follow-up monitoring, most frequently on an annual basis, is required by the majority (71%) of programs. Patients considered to be at high risk and candidates for combined kidney-pancreas transplantation may be monitored more frequently. Annual screening for coronary artery disease is typically required for asymptomatic patients considered to be at high risk for covert disease. Noninvasive techniques are typically used, and a designated cardiologist is usually available to the transplant program. The dialysis nephrologist or the potential transplant recipient is expected to inform the transplant program of intercurrent events that may affect transplant candidacy. Standard health maintenance screening is required, together with the routine updating of serologic and other blood tests that may be relevant to the posttransplant course. Smaller transplant programs (<100 patients on the waiting list) are more likely to maintain closer contact with the wait-listed patients and to attempt to influence their treatment during dialysis and are less likely to cancel transplants because of unanticipated pretransplant medical problems. The work load necessitated by the follow-up monitoring of wait-listed patients was assessed and, in the absence of specific evidence-based information, a series of recommendations were developed to reflect current standards of practice and to suggest future research initiatives.

AB - The Clinical Practice Guidelines Committee of the American Society of Transplantation developed a survey to review the policies of kidney transplant programs in the United States with respect to the management of the steadily expanding waiting list for cadaveric kidneys. The survey was sent to 287 centers, and 192 (67%) responded. The survey indicated that regular follow-up monitoring, most frequently on an annual basis, is required by the majority (71%) of programs. Patients considered to be at high risk and candidates for combined kidney-pancreas transplantation may be monitored more frequently. Annual screening for coronary artery disease is typically required for asymptomatic patients considered to be at high risk for covert disease. Noninvasive techniques are typically used, and a designated cardiologist is usually available to the transplant program. The dialysis nephrologist or the potential transplant recipient is expected to inform the transplant program of intercurrent events that may affect transplant candidacy. Standard health maintenance screening is required, together with the routine updating of serologic and other blood tests that may be relevant to the posttransplant course. Smaller transplant programs (<100 patients on the waiting list) are more likely to maintain closer contact with the wait-listed patients and to attempt to influence their treatment during dialysis and are less likely to cancel transplants because of unanticipated pretransplant medical problems. The work load necessitated by the follow-up monitoring of wait-listed patients was assessed and, in the absence of specific evidence-based information, a series of recommendations were developed to reflect current standards of practice and to suggest future research initiatives.

UR - http://www.scopus.com/inward/record.url?scp=0036156876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036156876&partnerID=8YFLogxK

M3 - Article

C2 - 11805184

AN - SCOPUS:0036156876

VL - 13

SP - 528

EP - 535

JO - Journal of the American Society of Nephrology

JF - Journal of the American Society of Nephrology

SN - 1046-6673

IS - 2

ER -